Table 2.
Cytocines (pg/mL) | Without fibrosis | Incipient fibrosis | Moderate to severe | P |
---|---|---|---|---|
median (min–max) | (n = 30) | (n = 25) | Fibrosis (n = 17) | |
IL-5 | ||||
Without antigen | 31.2 (31.2–112.2) | 31.2 (31.2–75.5) | 31.2 (31.2–127.8) | ns |
SWAP | 374.4 (31.2–5153.0) | 524 (31.2–5905.0) | 1988.0 (31.2–5135.0) | ns |
SEA | 36.8 (31.2–3820.0) | 188.4 (31.2–4232.0) | 310.9 (31.2–4256.0) | 0.0418 a |
IL-13 | ||||
Without antigen | 112.4 (93.8–186.8) | 93.8 (93.8–166.0) | 93.8 (93.8–93.8) | ns |
SWAP | 246.6 (93.8–1518.0) | 190.3 (93.8 –1290.0) | 213.7 (93.8–2091.0) | ns |
SEA | 171.2 (93.8–1497.0) | 93.8 (93.8–1442.0) | 93.8 (93.8–1857.0) | ns |
IL-17 | ||||
Without antigen | 15.6 (15.6–132.9) | 15.6 (15.6–84.1) | 15.6 (15.6–90.7) | ns |
SWAP | 21.4 (15.6–790.5) | 57.1 (15.6–974.8) | 21.4 (15.6–345.2) | ns |
SEA | 18.9 (15.6–291.1) | 15.6 (15.6–615.3) | 27.2 (15.6–557.5) | ns |
IFN-γ | ||||
Without antigen | 31.2 (31.2–276.2) | 31.9 (31.2–1788.0) | 31.2 (31.2–777.7) | ns |
SWAP | 73.1 (31.2–3038.0) | 1205.0 (31.2–5507.0) | 215.8 (31.2–5249.0) | ns |
SEA | 83.1 (31.2–288.0) | 203.8 (31.2–2905.0) | 130.1 (31.2–2714.0) | ns |
TNF-α | ||||
Without antigen | 61.9 (31.2–633.3) | 346.6 (31.2–2421.0) | 488.7 (31.2–3229.0) | 0.0182 a |
SWAP | 756.1 (80.6–3366.0) | 1446.0 (236.4–3057.0) | 1002.0 (35.7–2351.0) | 0.0319 b |
SEA | 389.8 (102.7–2521.0) | 827.3 (31.2–3551.0) | 927.3 (89.1–2517.0) | ns |
IL-10 | ||||
Without antigen | 15.6 (15.6–705.5) | 48.6 (15.6–1486.0) | 17.5 (15.6–1262.0) | ns |
SWAP | 393.8 (22.1–1976.0) | 399.6 (15.6–1779.0) | 318.1 (15.6–1213.0) | ns |
SEA | 585.7 (175.7–2075.0) | 1342.0 (15.6–2472.0) | 745.8 (35.5–1543.0) | ns |
*Kruskal-Wallis; awithout fibrosis versus moderate to severe fibrosis; bwithout fibrosis versus incipient fibrosis; ns: not significant (P > 0.05).
SWAP: soluble worm antigen preparation of adult Schistosoma mansoni; SEA: Schistosoma mansoni egg antigen.